Author： Slater Sarah Dumas Cameron Bubley Glenn
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.11, Iss.2, 2012-03, pp. : 325-330
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dutasteride chemoprevention worth it for prostate cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. :
Access to resources
Recommend
Dutasteride for the treatment of benign prostatic hyperplasia
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. :
Dutasteride: A Review of its Use in the Management of Prostate Disorders
By Keam Susan J. Scott Lesley J.
Drugs, Vol. 68, Iss. 4, 2008-01 ,pp. :
Prostate cancer: dutasteride a good bet for chemoprevention . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 630, 2011-01 ,pp. :
Drugs & Aging, Vol. 20, Iss. 12, 2003-01 ,pp. :